A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors

Clinically aggressive disease behavior is difficult to predict in men with low to intermediate clinical risk prostate cancer and methylation biomarkers may be a valuable adjunct for assessing the management of these patients. We set to evaluate the utility of DNA methylation to identify high risk di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Amar S., Vasiljević, Nataša, Carter, Paul, Berney, Daniel M, Møller, Henrik, Foster, Christopher S., Cuzick, Jack, Lorincz, Attila T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342126/
https://www.ncbi.nlm.nih.gov/pubmed/27708246
http://dx.doi.org/10.18632/oncotarget.12377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342126/
https://www.ncbi.nlm.nih.gov/pubmed/27708246
http://dx.doi.org/10.18632/oncotarget.12377

Ejemplares similares